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background: Bleeding and thromboembolic events (TE) are common complications after HeartMate II (HMII) left ventricular assist device 
implantation. We reviewed our experience and attempted to identify factors associated with these events.
Methods: We retrospectively reviewed 70 consecutive patients who received HMII from May 2006 to December 2011 at a single center. Warfarin 
was started on post-operative day 2 or 3 to maintain INR between 2 and 3 along with daily low dose aspirin. Patients were followed for 12 months or 
until cardiac transplantation, device explantation or death. Bleeding was defined by INTERMACS criteria but included intracranial bleeding events.
results: There were 48 bleeding events in 28 (40%) patients. The most common event was gastrointestinal bleeding (54.2%). Most events, 56% 
occurred at INR of ≥2 and 70.4% occurred within 4 months of HMII implantation. Bleeding was associated with high average INR and glomerular 
filtration rate of <60 ml/min/1.73 m2. There were 12 TE events in 9 patients (12.9%) of which ischemic stroke was most common (75%). No TE 
event occurred at INR >3. Most events, 66.7% occurred at an INR of <2 and 58.3% happened in <90 days. TE events were associated with young 
age and non-diabetes mellitus status. Bleeding and TE events were not associated with pulsatility index.
conclusion: Different factors are associated with bleeding and TE events. The suitable INR range for HMII patients should be chosen to balance 
the risk between these events, based largely on patient factors. 
Characteristics
Patients with 
Bleeding (n=28)
Patients without 
Bleeding (n=42)
p
Patients with TE 
events (n=9)
Patients without TE 
events (n=61)
p
Avg Age (years) 56.3+/-9.9 51.2+/-11 0.06 46.0+/-15.6 54.2+/-10.2 0.04
Male Gender (%) 78.6 83.3 0.60 88.9 82.0 0.61
Avg BMI (kg/sqm) 30.2+/-5.3 29.4+/-6.3 0.29 32.9+/-5.6 29.0+/-5.9 0.09
Ischemic cardiomyopathy (%) 42.9 47.6 0.70 55.6 44.2 0.53
Avg HMII speed (rpm) 9047+/-411 9105+/-310 1.00 9017+/-315 9079+/-377 0.70
Avg INR 2.47+/-0.43 2.09+/-0.38 0.04 2.16+/-0.5 2.17+/-0.46 0.70
GFR<60ml/min/1.73 m2 (%) 64.3 38.1 0.03 33.3 50.8 0.33
Diabetics (%) 53.6 40.4 0.30 12.5 50.8 0.03
INTERMACS profile </=3 (%) 71.1 52.4 0.11 44.4 62.2 0.31
